Showing results (121-130 of 163) with videos related to

Sort By:
Pageof 17
Cancers|June 6, 2019
Pulmonary Carcinoid Surface Receptor Modulation Using Histone Deacetylase InhibitorsRachael E Guenter, Tolulope Aweda, Danilea M Carmona Matos, et al.
Pharmaceuticals (Basel, Switzerland)|March 27, 2025
PET Imaging Expedites Detection of Aberration in the Humanization of an Annexin A1 Targeting AntibodyHailey A Houson, Brian D Wright, Solana R Fernandez, et al.
Current Radiopharmaceuticals|January 13, 2021
Accelerator Production of Scandium Radioisotopes: Sc-43, Sc-44, and Sc-47Margarita Chernysheva, Shaun C Loveless, Tom Brossard, et al.
Scientific Reports|March 23, 2025
Characterizing SSTR2 expression and modulation for targeted imaging and therapy in preclinical models of triple-negative breast cancerShannon E Lynch, Corinne I Crawford, Hailey A Houson, et al.
Molecular Imaging and Biology|August 12, 2025
PET Imaging of Diabetes-Induced Alterations in Metabolism and Immune ActivationShannon E Lynch, Heba M Alsheikh, Patrick N Song, et al.
Molecular Imaging and Biology|May 6, 2016
[89Zr]Trastuzumab: Evaluation of Radiation Dosimetry, Safety, and Optimal Imaging Parameters in Women with HER2-Positive Breast CancerRichard Laforest, Suzanne E Lapi, Reiko Oyama, et al.
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|September 23, 2021
A heavy-ion production channel of 149Tb via 63Cu bombardment of 89YJohn T Wilkinson, Kendall E Barrett, Samuel J Ferran, et al.
Theranostics|August 15, 2019
Current and Future Imaging Methods for Evaluating Response to Immunotherapy in Neuro-OncologyBenjamin B Kasten, Neha Udayakumar, Jianmei W Leavenworth, et al.
ACS Omega|March 3, 2025
[45Ti]Ti-HOPOs: Potential Complexes for the Development of 45Ti PET Imaging AgentsShefali Saini, N V S Dinesh K Bhupathiraju, Samith B Jayawardana, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|July 21, 2026
Development and characterization of [47Sc]Sc-NOTA-trastuzumab for targeted radiotherapy in primary and metastatic HER2 + breast cancerPatrick N Song, Shelbie J Cingoranelli, Sharmila Sridhar, et al.
Pageof 17